Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Morgan Stanley Maintains Equal-Weight on Criteo, Raises Price Target to $39
Morgan Stanley analyst Brian Nowak maintains Criteo (NASDAQ:CRTO) with a Equal-Weight and raises the price target from $30 to $39.
Marin Software Integrates with Criteo’s Commerce Media Platform to Expand eCommerce Advertising
Marin Software, a leading provider of digital marketing software for performance-driven advertisers and agencies, today announced an integration with Criteo's Commerce Media Platform. The integration will allow
Rosenblatt Maintains Buy on Criteo, Raises Price Target to $55
Rosenblatt analyst Mark Zgutowicz maintains Criteo (NASDAQ:CRTO) with a Buy and raises the price target from $45 to $55.
Criteo Beats On Q2 Earnings, Expands Margins, Issues Robust Q3 Outlook
Criteo SA (NASDAQ:CRTO) reported second-quarter FY21 revenue ex-TAC growth of 22% Y/Y to $220.2 million, beating the analyst consensus of $208.7…
Criteo: Q2 Earnings Insights
Shares of Criteo (NASDAQ:CRTO) rose 1.0% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 133.33% year over year to $0.63, which beat the estimate of $0.47.
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Analyzing Criteo’s Unusual Options Activity
Shares of Criteo (NASDAQ:CRTO) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved up to $39.98.
9 Communication Services Stocks With Unusual Options Alerts In Today’s Session
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.